Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

37-48 of 242 results
Page 4 of 21
Key Publications November 7, 2022

Compounding benefits of cholesterol-lowering therapy for the reduction of major cardiovascular events: systematic review and meta-analysis.

Circ Cardiovasc Qual Outcomes. 2022;15:e008552

Wang N, Woodward M, Huffman MD, Rodgers A
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications October 19, 2022

Time to clinical benefit of intensive blood pressure lowering in patients 60 years and older with hypertension: a secondary analysis of randomized clinical trials.

JAMA Intern Med. 2022;182:660-667

Chen T, Shao F, Chen K, Wang Y, Wu Z, Wang Y, Gao Y, Cornelius V, Li C, Jiang Z
Age Clinical Trials Hypertension
Key Publications October 18, 2022

Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trials.

J Am Heart Assoc. 2022;11:e025071

Zhang X, Ritonja JA, Zhou N, Chen BE, Li X
Clinical Trials Hypertension Nutrition
Key Publications October 7, 2022

Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.

Am J Clin Nutr. 2022;115:1490-1500

Sesso HD, Manson JE, Aragaki AK, Rist PM, Johnson LG, Friedenberg G, Copeland T, Clar A, Mora S, Moorthy MV, Sarkissian A, Carrick WR, Anderson GL, COSMOS Research Group
Cardiovascular Disease Clinical Trials Nutrition
Key Publications October 7, 2022

Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.

Am J Clin Nutr. 2022;115:1501-1510

Sesso HD, Rist PM, Aragaki AK, Rautiainen S, Johnson LG, Friedenberg G, Copeland T, Clar A, Mora S, Moorthy MV, Sarkissian A, Wactawski-Wende J, Tinker LF, Carrick WR, Anderson GL, Manson JE COSMOS Research Group
Cardiovascular Disease Clinical Trials Nutrition
Key Publications September 21, 2022

Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population.

BMJ. 2022;377:e066222

Kawahara T, Suzuki G, Mizuno S, Inazu T, Kasagi F, Kawahara C, Okada Y, Tanaka Y
Clinical Trials Diabetes Nutrition
Key Publications September 5, 2022

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.

Lancet. 2022;399:1876-1885

Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A et al.
Cardiovascular Disease Clinical Trials Nutrition
Key Publications August 30, 2022

Optimizing dyslipidemic cardiovascular residual risk reduction with icosapent ethyl in post-mi patients.

J Am Coll Cardiol. 2022;79:1672-1674

Boden WE, Andersson C
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications August 29, 2022

Prevention of cardiovascular events and mortality with icosapent ethyl in patients with prior myocardial infarction.

J Am Coll Cardiol. 2022;79:1660-1671

Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM, REDUCE-IT Investigators
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications August 22, 2022

Healthy lifestyle and life expectancy with and without Alzheimer's dementia: population based cohort study.

BMJ. 2022;377:e068390

Dhana K, Franco OH, Ritz EM, Ford CN, Desai P, Krueger KR, Holland TM, Dhana A, Liu X, Aggarwal NT, Evans DA, Rajan KB
Brain Health Clinical Trials Prevention
Key Publications August 22, 2022

Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United Kingdom.

Diabetes Obes Metab. 2022;24:289-295

Webb J, Mount J, von Arx LB, Rachman J, Spanopoulos D, Wood R, Tritton T, Massey O, Idris I
Cardiovascular Disease Clinical Trials Diabetes
Key Publications August 19, 2022

The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.

Diabetes Obes Metab. 2022;24:281-288

Zobel EH, von Scholten BJ, Hansen TW, Persson F, Rasmussen S, Wolthers B, Rossing P
Clinical Trials Diabetes Obesity
of 21